View in EDS

Anti-VEGFR2 therapy delays growth of preclinical pediatric tumor models and enhances anti-tumor activity of chemotherapy.

Saved in:
Bibliographic Details
Title: Anti-VEGFR2 therapy delays growth of preclinical pediatric tumor models and enhances anti-tumor activity of chemotherapy.
Authors: Lowery CD; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Blosser W; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Dowless M; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Renschler M; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Perez LV; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Stephens J; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Pytowski B; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Wasserstrom H; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Stancato LF; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Falcon B; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.
Source: Oncotarget [Oncotarget] 2019 Sep 17; Vol. 10 (53), pp. 5523-5533. Date of Electronic Publication: 2019 Sep 17 (Print Publication: 2019).
Publication Type: Journal Article
Journal Info: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31565186
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Anti-VEGFR2 therapy delays growth of preclinical pediatric tumor models and enhances anti-tumor activity of chemotherapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lowery+CD%22">Lowery CD</searchLink>; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Blosser+W%22">Blosser W</searchLink>; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Dowless+M%22">Dowless M</searchLink>; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Renschler+M%22">Renschler M</searchLink>; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Perez+LV%22">Perez LV</searchLink>; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Stephens+J%22">Stephens J</searchLink>; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Pytowski+B%22">Pytowski B</searchLink>; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Wasserstrom+H%22">Wasserstrom H</searchLink>; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Stancato+LF%22">Stancato LF</searchLink>; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Falcon+B%22">Falcon B</searchLink>; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101532965%22">Oncotarget</searchLink> [Oncotarget] 2019 Sep 17; Vol. 10 (53), pp. 5523-5533. <i>Date of Electronic Publication: </i>2019 Sep 17 (<i>Print Publication: </i>2019).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Impact+Journals%22">Impact Journals </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101532965 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1949-2553 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219492553%22">19492553 </searchLink><i>NLM ISO Abbreviation: </i>Oncotarget <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31565186
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.18632/oncotarget.27148
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 5523
    Titles:
      – TitleFull: Anti-VEGFR2 therapy delays growth of preclinical pediatric tumor models and enhances anti-tumor activity of chemotherapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lowery CD
      – PersonEntity:
          Name:
            NameFull: Blosser W
      – PersonEntity:
          Name:
            NameFull: Dowless M
      – PersonEntity:
          Name:
            NameFull: Renschler M
      – PersonEntity:
          Name:
            NameFull: Perez LV
      – PersonEntity:
          Name:
            NameFull: Stephens J
      – PersonEntity:
          Name:
            NameFull: Pytowski B
      – PersonEntity:
          Name:
            NameFull: Wasserstrom H
      – PersonEntity:
          Name:
            NameFull: Stancato LF
      – PersonEntity:
          Name:
            NameFull: Falcon B
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 17
              M: 09
              Text: 2019 Sep 17
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1949-2553
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 53
          Titles:
            – TitleFull: Oncotarget
              Type: main
ResultId 1